Expression of bcl-2 in oral squamous cell carcinoma: An immunohistochemical study of 90 cases with clinico-pathological correlations

Oncology Reports

Volumn 10, Issue 2, 2003, Pages 285-291

  Lo Muzio, Lorenzo ^a   Mignogna, M D ^b   Pannone, G ^b   Rubini, C ^a   Grassi, R ^c   Nocini, P F ^d   Ferrari, F ^d   Serpico, R ^c   Favia, G ^c   De Rosa, G ^b   Maiorano, E ^b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d UNIVERSITY OF VERONA   (Italy)

Author keywords

Apoptosis; Bcl 2; Mouth; Oral mucosa; Squamous cell carcinoma

Indexed keywords

PROTEIN BCL 2;

AGED; ARTICLE; CANCER STAGING; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; LYMPH NODE; MALE; METABOLISM; MORTALITY; MOUTH MUCOSA; MOUTH TUMOR; PATHOLOGY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPH NODES; MALE; MOUTH MUCOSA; MOUTH NEOPLASMS; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS C-BCL-2; SURVIVAL RATE;

EID: 18544411903     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.10.2.285     Document Type: Article

References (51)

1. Vaux DL, Haecker G and Strasser A: An evolutionary perspective on apoptosis. Cell 76: 777-779, 1994. (Pubitemid 24085313)
2. Sternberg SS: Histology for Pathologist. Lippincott-Raven Publishers, Philadelphia, 1997.
3. Jameson JL: Principles of Molecular Medicine. Humana Press, Totowa, NJ, 1998.
4. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462, 1995.
5. Yang E and Korsmeyer SJ: Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 88: 386-401, 1996. (Pubitemid 26240369)
6. Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555-556, 1980.
7. Oberhammer F, Wilson JW, Dive C, Morris ID, Hickman JA, Wakeling AE, Walker PR and Sikorska M: Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 12: 3679-3684, 1993. (Pubitemid 23256455)
8. Martin SJ and Green DR: Protease activation during apoptosis: death by a thousand cuts? Cell 82: 349-352, 1995.
9. Wyllie AH: The genetic regulation of apoptosis. Curr Opin Genet Dev 5: 97-104, 1995.
10. Miura M, Zhu H, Rotello R, Hartwieg EA and Yuan J: Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75: 653-660, 1993. (Pubitemid 23346364)
11. Allen RT, Cluck MW and Agrawal DK: Mechanisms controlling cellular suicide: role of Bcl-2 and caspases. Cell Mol Life Sci 54: 427-445, 1998. (Pubitemid 28260595)
12. Reed JC: Promise and problems of Bcl-2 antisense therapy. J Natl Cancer Inst 89: 988-990, 1997.
13. Reed JC: Bcl-2 family proteins. Oncogene 17: 3225-3236, 1998.
14. Crook NE, Clem RJ and Miller LK: An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. J Virol 67: 2168-2174, 1993. (Pubitemid 23088392)
15. Vaux DL, Cory S and Adams JM: Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335: 440-442, 1988.
16. La Casse EC, Baird S, Korneluk RG and MacKenzie AE: The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 17: 3247-3259, 1998. (Pubitemid 29043977)
17. Sobin LH and Wittekind C: TNM Classification of Malignant Tumours. 5th edition. John Wiley & Sons, Inc., New York, 1997.
18. Chen Y, Kayano T and Takagi M: Dysregulated expression of bcl-2 and bax in oral carcinomas: evidence of post-transcriptional control. J Oral Pathol Med 29: 63-69, 2000. (Pubitemid 30104869)
19. Singh BB, Chandler FW Jr, Whitaker SB and Forbes-Nelson AE: Immunohistochemical evaluation of bcl-2 oncoprotein in oral dysplasia and carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85: 692-698, 1998. (Pubitemid 128641972)
20. Staibano S, Mignogna MD, Lo Muzio L, Di Alberti L, Di Natale E, Lucariello A, Mezza E, Bucci E and De Rosa G: Overexpression of cyclin-D1, bcl-2, and bax proteins, proliferating cell nuclear antigen (PCNA), and DNA-ploidy in squamous cell carcinoma of the oral cavity. Hum Pathol 29: 1189-1194, 1998. (Pubitemid 28525516)
21. Tsujimoto Y, Cossman J, Jaffe E and Croce CM: Involvement of the bcl-2 gene in human follicular lymphoma. Science 228: 1440-1443, 1985. (Pubitemid 15041322)
22. Hockenbery D, Nunez G, Milliman C, Schreiber RD and Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334-336, 1990. (Pubitemid 120029101)
23. Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W and Reed JC: Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 53: 4701-4714, 1993. (Pubitemid 23304404)
24. Krajewski S, Chatten J, Hanada M and Reed JC: Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein. Lab Invest 72: 42-54, 1995.
25. Krajewski S, Bodrug S, Gascoyne R, Berean K, Krajewska M and Reed JC: Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes. Am J Pathol 145: 515-525, 1994. (Pubitemid 24285958)
26. Lipponen P, Pietilainen T, Kosma VM, Aaltomaa S, Eskelinen M and Syrjanen K: Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis. J Pathol 177: 49-55, 1995.
27. Chan WK, Mole MM, Levison DA, Ball RY, Lu QL, Patel K and Hanby AM: Nuclear and cytoplasmic bcl-2 expression in endometrial hyperplasia and adenocarcinoma. J Pathol 177: 241-246, 1995.
28. Bronner MP, Culin C, Reed JC and Furth EE: The bcl-2 protooncogene and the gastrointestinal epithelial tumor progression model. Am J Pathol 146: 20-26, 1995.
29. Tron VA, Krajewski S, Klein-Parker H, Li G, Ho VC and Reed JC: Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma. Am J Pathol 146: 643-650, 1995.
30. Mosnier JF, Perret AG, Brunon J and Boucheron S: Expression of the bcl-2 oncoprotein in meningiomas. Am J Clin Pathol 106: 652-659, 1996. (Pubitemid 26392771)
31. Schorr K, Li M, Krajewski S, Reed JC and Furth PA: Bcl-2 gene family and related proteins in mammary gland involution and breast cancer. J Mammary Gland Biol Neoplasia 4: 153-164, 1999.
32. Wilson GD, Saunders MI, Dische S, Richman PI, Daley FM and Bentzen SM: bcl-2 expression in head and neck cancer: an enigmatic prognostic marker. Int J Radiat Oncol Biol Phys 49: 435-441, 2001. (Pubitemid 32120241)
33. Stoll C, Baretton G, Ahrens C and Lohrs U: Prognostic significance of apoptosis and associated factors in oral squamous cell carcinoma. Virchows Arch 436: 102-108, 2000. (Pubitemid 30128755)
34. Hotz MA, Bosq J, Zbaeren P, Reed J, Schwab G, Krajewski S, Brousset P and Borner MM: Spontaneous apoptosis and the expression of p53 and Bcl-2 family proteins in locally advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 125: 417-422, 1999. (Pubitemid 29169768)
35. Pena JC, Thompson CB, Recant W, Vokes EE and Rudin CM: Bcl-xL and Bcl-2 expression in squamous cell carcinoma of the head and neck. Cancer 85: 164-170, 1999. (Pubitemid 29031371)
36. Giatromanolaki A, Koukourakis M, Zaramboukas T, Skordalaki A, Arapantoni P, Georgoulias V and Fountzilas G: p53 and bcl-2 expression in locally advanced squamous cell head-neck cancer treated with platinum based chemotherapy and radiotherapy. Anticancer Res 18: 4685-4692, 1998. (Pubitemid 29042044)
37. Drenning SD, Marcovitch AJ, Johnson DE, Melhem MF, Tweardy DJ and Grandis JR: Bcl-2 but not Bax expression is associated with apoptosis in normal and transformed squamous epithelium. Clin Cancer Res 4: 2913-2921, 1998. (Pubitemid 28523523)
38. Kannan K, Latha PN and Shanmugam G: Expression of bcl-2 oncoprotein in Indian oral squamous cell carcinomas. Oral Oncol 34: 373-376, 1998. (Pubitemid 28440298)
39. Schoelch ML, Le QT, Silverman S Jr, McMillan A, Dekker NP, Fu KK, Ziober BL and Regezi JA: Apoptosis-associated proteins and the development of oral squamous cell carcinoma. Oral Oncol 35: 77-85, 1999. (Pubitemid 28546848)
40. Loro LL, Vintermyr OK, Liavaag PG, Jonsson R and Johannessen AC: Oral squamous cell carcinoma is associated with decreased bcl-2/bax expression ratio and increased apoptosis. Hum Pathol 30: 1097-1105, 1999. (Pubitemid 29427168)
41. Birchall MA, Schock E, Harmon BV and Gobe G: Apoptosis, mitosis, PCNA and bcl-2 in normal, leukoplakic and malignant epithelia of the human oral cavity: prospective, in vivo study. Oral Oncol 33: 419-425, 1997. (Pubitemid 28126040)
42. Ravi D, Nalinakumari KR, Rajaram RS, Nair MK and Pillai MR: Expression of programmed cell death regulatory p53 and bcl-2 proteins in oral lesions. Cancer Lett 105: 139-146, 1996. (Pubitemid 26252585)
43. Sulkowska M, Famulski W, Chyczewski L and Sulkowski S: Evaluation of p53 and bcl-2 oncoprotein expression in precancerous lesions of the oral cavity. Neoplasma 48: 94-98, 2001. (Pubitemid 32428538)
44. Lavieille JP, Gazzeri S, Riva C, Reyt E, Brambilla C and Brambilla E: p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck. Anticancer Res 18: 4741-4749, 1998. (Pubitemid 29042054)
45. Homma A, Furuta Y, Oridate N, Nakano Y, Kohashi G, Yagi K, Nagahashi T, Fukuda S, Inoue K and Inuyama Y: Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy. Clin Cancer Res 5: 801-806, 1999. (Pubitemid 29180831)
46. Gasparini G, Bevilacqua P, Bonoldi E, Testolin A, Galassi A, Verderio P, Boracchi P, Guglielmi RB and Pezzella F: Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy. Clin Cancer Res 1: 1375-1383, 1995.
47. Xie X, Clausen OP, De Angelis P and Boysen M: The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue. Cancer 86: 913-920, 1999. (Pubitemid 29439843)
48. Friedman M, Grey P, Venkatesan TK, Bloch I, Chawla P, Caldarelli DD and Coon JS: Prognostic significance of Bcl-2 expression in localized squamous cell carcinoma of the head and neck. Ann Otol Rhinol Laryngol 106: 445-450, 1997. (Pubitemid 27259863)
49. Wilson GD, Grover R, Richman PI, Daley FM, Saunders MI and Dische S: Bcl-2 expression correlates with favourable outcome in head and neck cancer treated by accelerated radiotherapy. Anticancer Res 16: 2403-2408, 1996. (Pubitemid 26326270)
50. Yao L, Iwai M and Furuta I: Correlations of bcl-2 and p53 expression with the clinicopathological features in tongue squamous cell carcinomas. Oral Oncol 35: 56-62, 1999. (Pubitemid 28546845)
51. Harada H, Mitsuyasu T, Seta Y, Maruoka Y, Toyoshima K and Yasumoto S: Overexpression of bcl-2 protein inhibits terminal differentiation of oral keratinocytes in vitro. J Oral Pathol Med 27: 11-17, 1998. (Pubitemid 28059162)